BioAdvance News

Niiki Pharma Developing New Weapons to Battle Cancer

By WebmasterJanuary 13, 2012November 1st, 2024No Comments

Niiki Pharma Developing New Weapons to Battle Cancer
Read more here

Previous PostNiiki Pharma Announces the Completion of Phase I Dose Escalation for First-in-Man Anti-Cancer Agent NKP-1339
Next PostYaupon Changes Name to Ceptaris Therapeutics, Inc.